Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Parasitology ; 149(2): 145-154, 2022 02.
Article in English | MEDLINE | ID: mdl-34579797

ABSTRACT

The incidence rate of inflammatory bowel diseases is increasing in developed countries. As such there is an increasing demand for new therapies. The aim of this systematic review was to investigate whether there is evidence to support the use of helminth therapy for the management of Crohn's disease and ulcerative colitis. Four databases (PubMed, Embase, Medline and the Cochrane Central Register of Control Trials) were searched for primary evidence in the form of clinical studies. Nine studies were suitable for inclusion: five double-blind randomized control trials and four open-label studies. This review divided the results of the studies into two categories: (a) the efficacy of helminth therapy and (b) the safety of helminth therapy. Results regarding the efficacy were mixed and a conclusive answer could not be reached, as there was not enough evidence to rule out a placebo effect. More research is needed, particularly studies with control groups to address the possibility of a placebo effect. Despite this, all nine studies concluded helminth therapy was safe and tolerable, and therefore there is currently no evidence against further exploration of this treatment option.


Subject(s)
Colitis, Ulcerative , Crohn Disease , Helminths , Inflammatory Bowel Diseases , Animals , Colitis, Ulcerative/drug therapy , Crohn Disease/therapy , Incidence , Randomized Controlled Trials as Topic
2.
J Med Internet Res ; 7(3): e25, 2005 Jul 01.
Article in English | MEDLINE | ID: mdl-15998616

ABSTRACT

The National Cancer Institute (NCI) was among the first federal agencies to recognize the potential of the Internet for disseminating health-related information. The evolution and refinement of NCI's online cancer information has been substantially "user driven"-from the launch of CancerNet in 1995 to the recent redesign of its award-winning successor, the NCI website. This article presents an overview of NCI's multi-pronged approach to gathering input about its online information products, including stakeholder meetings, focus groups, standard and customized online user surveys, usability testing, heuristic reviews, and search log analysis. Also highlighted are some of the many enhancements that have been made to NCI's online cancer information products based on user input.


Subject(s)
Consumer Behavior , National Institutes of Health (U.S.) , Neoplasms/therapy , Online Systems/statistics & numerical data , Patient Satisfaction , Clinical Trials as Topic , Humans , Information Services , Language , Neoplasms/classification , Reproducibility of Results , Research Design , Surveys and Questionnaires , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...